HOME >> BIOLOGY >> NEWS
Study in Royal Society journal on holly as an indicator of climate change

ida, 140 Seventh Ave. South, ST. PETERSBURG, FLORIDA, 33701, United States

Genetic Diversity Predicts Pathogen Resistance and Cell-mediated Immunocompetence in House Finches by Ms DM Hawley, Dr. KV Sydenstricker, Dr GV Kollias and Professor AA Dhondt
Scientists have long suspected that genetic diversity influences individual health, but this idea had not been tested in an experimental setting where the playing field is leveled. We investigated whether house finches with less genetic variation become more severely diseased in response to a pathogen challenge. Finches with lower genetic variation showed more severe eye symptoms that are characteristic of infections from this naturally-occurring pathogen. The stronger symptoms may reflect compromised immunity: when we challenged birds with a T-cell stimulant, less genetically variable birds mounted weaker responses. Our study provides direct support that genetic variation impacts individual disease resistance and immunity.
Contact: Ms DM Hawley, Ecology and Evolutionary Biology, Cornell University, Corson Hall, ITHACA, NEW YORK, 14853, United States

No sex difference in yolk steroid concentrations of avian eggs at laying by Dr KM Pilz, Professor E Adkins-Regan and Dr H Schwabl
Bird eggs contain steroids of maternal origin. These maternal steroids affect offspring development, and have been hypothesised to influence offspring sex. However, previous studies of the sex-determination hypothesis have examined steroid levels in incubated eggs, which may not accurately reflect maternal steroid levels. We conducted the first study relating steroid concentrations in unincubated eggs with the embryonic sex of offspring, as determined by genetic sexing. Steroid concentrations of male and female eggs were not different in unincubated eggs, but were different in incubated eggs. Thus, maternal steroids do not appear to play a critical role in avian sex determination.
Contact
'"/>

Contact: Tim Watson
tim.watson@royalsoc.ac.uk
44-207-451-2508
Royal Society
28-Jun-2005


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused ... Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine ... and is expected to deliver therapeutic levels of olanzapine for a period of 3 ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
Cached News: